The permeability of the blood—brain barrier during electrically induced seizures in man

The blood-brain barrier (BBB) in man was studied during various conditions using the indicator dilution method of Crone [8]. Using 113m In-DTPA as reference substance the extraction, E, of the small test substances 24Na+, 36Cl-, 14C-urea and 14C-thiourea was estimated from the areas under the venous outflow curves following intracarotid slug injection of tracers. Interlaminar diffusion and red cell carriage were taken into consideration when calculating E. Cerebral blood flow (CBF) was measured using the intra-arterial 133Xe-injection method. Twenty-two patients receiving electroconvulsive therapy (ECT) were studied before and during seizures and during hypercapnia. Before seizures the extraction values in % were as follows: ENa+ 1.6, ECl- 1.9, Eurea 3.9 and Ethiourea 7.8; the corresponding values for the permeability-surface area products (PS) in ml/100 g x min were 0.5, 0.3, 0.7, 4.1, respectively. During seizure a decrease of Ethiourea and an increase of PSurea were significant. During hypercapnia PSNa and PSthiourea rose significantly. Due to the similarity of the findings in those two high flow situations it is suggested that the changes of CBF and not the epileptic activity are responsible for the changes in permeability. The mechanism of action may be a stretching of endothelial cells in the cerebral vessels or an opening up of new capillaries, or a combination of both.     

Practical Aspects of Rate Adaptive Atrial (AAI,R) Pacing: Clinical Experiences in 44 Patients

Forty-four patients with sinus node disease and chronotropic incompetence but no evidence of AV conduction disturbances were treated with rate adaptive atriul (AAI,R) pacemakers. Medtronic Activitrax and Siemens Sensolog activity sensing single chamber pulse generators were used. Twentyfour patients (55%) had the bradycardia-tachycardia syndrome. The mean folloiw-up time is 20 ± 14 months (range 1–48, median 17 months). All patients remain alive. Two patients were reoperated upon for lead problems without change of pacing mode. One patient developed symptomatic: srecond-degree Wenckebach block during follow-up, and received a DDD,R system. Although 22 of the patients were treated with antiarrhythmic drugs postoperatively, no further cases of significant AV conduction disturbances were seen. During rapid atrial pacing, exercise-induced enhancement of AV conduction was a consistent finding, although less pronounced in patients treated with beta-blocking drugs. One patient developed permanent atrial fibrillation with an adequate ventricular rate. By systematic reprogramming procedures, QRS complex sensing through the atrial electrode could be demonstrated in 25 patients (23/28 with unipolar and 2/16 with bipolar leads). it could be counteracted effectively by pulse generator program selection in all cases. Forty-two of 44 patients (95%) remain in AAI,R pacing with normal function, Rate adaptive atrial pacing can be successfully applied in this patient group.     

Reflex Cardiac Asystole

In this report we present the case of a patient with recurrent syucopal episodes. During one of the attacks the patient was monitoring by telemetry and the ECC lead showed asvstole for more than 7 seconds. As in cases of the carhlinhibitory type of hypersenstive carolid sinus svndrome [HCSS]. asvstole may represent suppression of the sinus node or suppression of both sinus and atioventricular [AV] node. Unfortunately, in contrast to HCSS, there is no maneuver that can reproducibly induce episodes of asystole. Consequentlty, very little is known about the occurrence of AV block in the presence of sinus arrest. In the patient described in this report. We were able to demonstrate that suppression of sinus and AV nodes occured simultaneously. This is interesting to note that in this type of syneope data from noninvasive and invasive techniques in assessing sinus nodal and AV nodal conduction may note be conclusive. In the group of patients with this type of syncope, permanent artial demand pacing is constraindicated.     

Influence of Different Conditioning Methods on Force and Fatigue Resistance in Chronically Stimulated Skeletal Muscles

A study was undertaken to compare different conditioning methods for the transformation of latissimus dorsi muscle into a fatigue resistant one for application in circulatory assist. In ten sheep four electrodes were sutured to the epineurium of the left thoracodorsal nerve for indirect electrical stimulation of the latissimus dorsi muscle. In six sheep a "carousel stimulation, " a special multichannel stimulation, in combination with a recently developed conditioning protocol was used for muscle conditioning ( multichannel method ). In four sheep, a conventional stimulation protocol using single channel stimulation was applied for transformation of the muscle (single channel method). The final experiments were carried out when fatigue resistance was obtained. The maximum tetanic forces at different preloads were determined and fatigue resistance was tested during 20 minutes of continuous stimulation. Both conditioning patterns led to fatigue-free chronic stimulation. Muscles conditioned by multichannel stimulation exhibited between 20% and 33% less force than the contralateral unconditioned muscles, whereas in the single channel group this loss was between 32% and 43%. Thus, the multichannel method revealed relatively superior in preserving muscle force for chronic stimulation.     

Comparison of a Unipolar Defibrillation System with a Dual Lead System Using an Enlarged Defibrillation Anode

The unipolar system for transvenous defibrillation, consisting of a single right ventricular lead as the cathode and the device shell as anode, has been shown to combine low de- fibrillation thresholds (DFTs) and simple implantation techniques. We compared the defibrillation efficacy of this system with the defibrillation efficacy of a dual lead system with a 12-cm long defibrillation anode placed in the left subclavian vein. The data of 38 consecutive patients were retrospectively analyzed. The implantation of an active can system was attempted in 20 patients (group 1), and of the dual lead system in 18 patients (group 2). Both groups had comparable demographic data, cardiac disease, ventricular function, or clinical arrhythmia. The criterion for successful implantation was a DFT of > 24 J. This criterion was met in all 18 patients of group 2, The active can system could not be inserted in 3 of the 20 group 1 patients because of a DFT > 24 J. In these patients, the implantation of one (n = 2) or two (n = 1) additional transvenous leads was necessary to achieve a DFT ≤ 24). The DFTs of the 17 successfully implanted group 1 patients were not significantly different from the 18 patients in group 2 (12.3 ± 5.7 f vs 10.8 ± 4.8 J). The defibrillation impedance was similar in both groups (50.1 ± 6.1 ± 48.9 ± 5.2 Ω). In group 1, both operation duration (66.8 ± 17 min vs 80.8 ± 11 min; P < 0.05) and fluoroscopy time (3.3 ± 2.1 min vs 5.7 ± 2.9 min; P < 0,05) were significantly shorter. Thus, the active can system allows reliable transvenous defibrillation and a marked reduction of operation duration and fluoroscopy time. The dual lead system, with an increased surface area defibrillation anode, seems to he a promising alternative for active can failures.     

The Left Subclavian Vein as an Alternative Site for Implantation of the Second Defibrillation Lead

The optimal placement for the second defibrillation lead in a twolead system has never been addressed. We retrospectively reviewed the data of 33 patients with an average age of 59.2 years (range 41–78 years), predominantly mala (n = 29), who underwent implantation of a cardioverter defibrillator (ICD) for treatment of ventricular tachycardia (n = 19) or ventricular fibrillation (n = 14). In all patients an attempt was made to implant an endovenous ICD device (leads only, no subcutaneous patch). In group I (n = 18) the defibrillation anode, a separate unipolar lead, was placed in the common position, the superior vena cava. In group II (n =15) the lead was placed in the left subclavian vein. At least two consecutive shocks reverting ventricular fibrillation at energies ±24J were required for implantation of the ICD device. All shocks were monophasic. The success rate of endovenous defibrillation was significantly higher in group II than in group I (67% vs 28%, P < 0.05). Thus, it could be demonstrated that the position of the defibrillation anode can influence the defibrillation efficacy in transvenous ICD systems. Prospective randomized trials are needed to investigate the optimal position for the second defibrillation electrode, which may gain increasing importance as soon as dual chamber ICDs become available.     

Choosing the Stimulation Rate in Patients with Intermittent Bradycardia and a Single Lead Pacemaker

In order to assess the prevalence of intermittent bradycardia in a pacemaker population, we retrospectively evaluated the occurrence of intrinsic heart activity in 229 patients with ventricular pacing. Spontaneous heart activity was recorded in 60% of the patients. However, the stimulation rate had been decreased in onJy 40% of the patients in order to allow for longer periods of intrinsic heart activity. In the second part of the study we prospectively assessed differences in pacemaker utilization in 19 patients with intermittent bradycardia and single lead pacemakers. All patients were observed over four periods of 14 days, with the following pacing modes: 70 heats/min, 50 beats/min, hysteresis sensing 50 beats/min, and pacing 70 heats/min; and search hysteresis sensing 50 beats/min and pacing 70 beats/min. Search hysteresis pacing is a new feature that theoretically allows for a shorter time of pacing than that of hysteresis pacing. A reduction in the stimulation rate from 70 beats/min to 50 beats/ min resulted in a 60% reduction in pacemaker utilization (P < 0.05). Search hysteresis decreased pacemaker utilization by 33% (P < 0.05) There was no statistical difference between conventional hysteresis and fixed rate pacing at 70 beats/min. Most patients found fixed rate pacing preferable to hysteresis pacing. In order to minimize battery consumption and to avoid unfavorable hemodynamics in patients with ventricular pacing, the stimulation mode and rate should be optimized in patients with intermittent bradycardia to allow for longer periods of intrinsic heart activity.     

Implantation of a Cardioverter/Defibrillator in the Subpectoral Region Combined with a Nonthoracotomy Lead System

An implantable cardioverter defibrillator was placed into a sub-pectoral pocket via the incision for cephalic venotomy during implantation of a nonthoracotomy lead system. The approach obviated another incision and subcutaneous tunneling of the leads. There were no perioperative complications and after 6 months of follow-up, the patient continues to tolerate the device satisfactorily.     

The renin-angiotensin system during converting enzyme inhibition with captopril in patients with severe treatment-resistant hypertension

Abstract. The effect of captopril on blood pressure (BP) and various components of the renin-angiotensin system was assessed in ten severely hypertensive patients. Captopril acutely reduced the BP with a maximum decrease of 23% at 90–120 min.
Maintenance treatment with captopril alone could not control the BP in any of the patients. Addition of hydrochlorothiazide markedly reduced the BP, while supplementation with propranolol caused no consistent changes.
Three patients attained a supine diastolic blood pressure (SDBP) ≤90 mmHg. Only two patients had a fall in SDBP less than 10 mmHg. One patient stopped because of taste disturbances.
Monitoring the renin-angiotensin system showed suppressed plasma concentrations of angiotensin II and increased levels of angiotensin I and renin, indicating the inhibition of converting enzyme activity. Plasma concentration of renin substrate decreased significantly. This observation has important implications for the methodology of renin assays.
Captropril is an effective alternative in the treatment of hypertensive patients not readily controlled with conventional therapy.